Clik here to view.
Our Top 10 Chemunity Posts of 2013
Posted By: Rachel WallaceAs we bid adieu to 2013 and set our sights on making 2014 an exciting year, we wanted to take a look back at the most influential and well read Chemunity posts of the past...
View ArticleClik here to view.
Digital Diagnostic Tools Go Mobile
Posted By: Rachel Wallace and Robin FranceschiSelf-diagnosis of medical conditions is not a new concept. Women have been peeing on sticks since the first home pregnancy kit was invented in 1968.The...
View ArticleClik here to view.
Future of Medtech: Who’s In, Who’s Out, Who’s Taking Over
Posted By: Rachel WallaceThe medical technology industry had its share of disappointments last year, with a slow pace of device approvals and meager action on the investment front. But a wave of...
View ArticleClik here to view.
Native Advertising Part 1: What Is It and Why Should I Care?
Posted By: Rachel WallaceThere’s a lot of buzz about native advertising in the marketing and media universe. But for all of the talk, it seems few people really know what native advertising is.Results...
View ArticleClik here to view.
Native Advertising Part 2: Both Sides of the Debate
Posted By: Rachel WallaceLove it or loathe it, the world of media and advertising has changed. With budget-crunched newsrooms cutting their staff to the bone, publications are exploring new advertising...
View ArticleClik here to view.
Native Advertising Part 3: Life Science Q&A With GEN’s Bill Levine
Posted By: Rachel WallaceA number of mainstream media outlets — including the New York Times and Fortune— have been early adopters of native advertising. But what about trade publications? And more...
View ArticleClik here to view.
Native Advertising for the Life Sciences: Navigating a New Type of Content
Posted By: Rachel WallaceThere’s a lot of buzz about native advertising in the life science marketing and media universe. But for all of the talk, it seems few people really know what native...
View ArticleClik here to view.
Want More Cures? Modernize Clinical Trials
Posted By: Rachel WallaceAs the federal government creates a plan to speed the pace of drug development in the U.S., one specialty contract research organization suggests that a more modernized...
View ArticleClik here to view.
Massachusetts Paves the Way for Rare Disease and Orphan Drug Development
Posted By: Rachel WallaceA recent article in the Boston Business Journal has revealed the full extent of the Bay State's booming rare disease research sector. Massachusetts is home to more of the...
View ArticleClik here to view.
A Bright Future for Pharma and Biotech in 2016
Posted By: Leida Tirado-Lee, PhD and Rachel WallaceBefore 2016 even officially kicked off, the life sciences industry received an early present to the tune of $32 billion. The House and Senate approved...
View Article
